Fundz

Hepta raises $6.7 million in seed funding led by Felicis Ventures and Illumina Ventures to enhance liquid biopsy technology for liver disease detection.

PRIVATENov 05, 2025

Amount Raised

$6.7 Million

Round Type

Seed

San FranciscoBiotechnologyHealth CareArtificial IntelligenceHealth Diagnosticsresearch

Investors

Alumni VenturesFelicisSeaX VenturesAME Cloud VenturesIllumina Ventures

Description

Hepta, a biotech company, has emerged from stealth with $6.7 million in seed funding. The funding, led by Felicis Ventures and Illumina Ventures, will help advance their liquid biopsy platforms. Hepta's technology interprets cfDNA to provide insights into chronic diseases, particularly liver disease. The company aims to improve diagnostic accuracy for MASH, a severe liver condition affecting millions.

Quick answer

Hepta raised $6.7 Million in a Seed round, dated November 5, 2025. Investors: Alumni Ventures, Felicis, SeaX Ventures, AME Cloud Ventures and Illumina Ventures. Hepta is based in San Francisco, California, United States.

How much did Hepta raise?
Hepta raised $6.7 Million in a Seed round on November 5, 2025.
Who invested in Hepta?
Alumni Ventures, Felicis, SeaX Ventures, AME Cloud Ventures and Illumina Ventures are named as investors in this round.
What does Hepta do?
Hepta detects chronic disease early by using cfDNA epigenetic analysis and AI to deliver accurate, non-invasive diagnostics at population scale.
Where is Hepta based and how big is it?
Hepta is based in San Francisco, California, United States. Fundz records about 1 employees.
Who are the decision-makers at Hepta?
Fundz holds 1 contact at Hepta, including the Co-founder & CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Health Diagnostics and research around the same time

Companies in the same sectors as Hepta that raised within 45 days of this round, from Fundz verified event records.

  • Uncovr raised $5.1M on December 11, 2025.
  • a2z Radiology AI raised $1.5M (Pre-Seed) on December 2, 2025.
  • Healthplus.ai raised $2.7M (Seed) on November 29, 2025.
  • Lumonus raised $18M (Series B) on November 6, 2025.
  • RADiCAIT raised $1.7M (Pre-Seed) on October 27, 2025.
  • Grail raised $325M (Post-IPO Equity) on October 20, 2025.

Who to call at Hepta, and when

A new round usually means Hepta is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Hepta raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hepta, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hepta. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hepta

Location

San Francisco, California, United States

About

Hepta detects chronic disease early by using cfDNA epigenetic analysis and AI to deliver accurate, non-invasive diagnostics at population scale. Founded by former Illumina, Grail and Google scientists, the company is backed by Felicis Ventures, Illumina Ventures, SeaX Ventures, Alumni Ventures, and AME Cloud Ventures. Hepta is proving that blood-based epigenetic biomarkers can replace invasive biopsies, enabling earlier and more accessible detection of diseases like MASH and laying the foundation for future applications across chronic diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hepta raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsHamed A., Co-founder & CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Hepta's next move

See what Strategic adds

Hepta raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.